Coeptis Therapeutics Could Go To The Moon This Week!

WEXFORD, Pa., May 10, 2023 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) ("Coeptis" or "the Company"), a biopharmaceutical...
Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Avalon GloboCare's (Nasdaq: ALBT) Fusion Gene Map Te...
Guess Who Picked Up Vanda Pharmaceuticals Inc. (NASD...
5am Ventures Llc. is Buying Pulmatrix Inc. (NASDAQ:P...

The last two news releases are below and it is creating massive volume spikes. We expect COEP to have a wonderful trading week so put it on your watchlist today.

WEXFORD, Pa., May 10, 2023 /PRNewswire/ — Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced that research involving its SNAP-CAR technology was detailed in a peer-reviewed article published in the peer-reviewed journal, Nature Communications. SNAP-CAR is a multi-antigen chimeric antigen receptor T cell (CAR T) technology that can be adapted to different cancer indications, including hematologic and solid tumors.

WEXFORD, Pa., May 17, 2023 /PRNewswire/ — Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or the “Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced today the appointment of Brian Cogley, MBA, to the position of Chief Financial Officer (CFO) effective immediately. Mr. Cogley brings 15 years of accounting and finance experience to Coeptis, having previously held positions of increasing authority at two “Big 4” accounting firms and served on the management teams of multiple companies in diverse industries. He succeeds Christine Sheehy, who will remain with Coeptis in a senior finance capacity and as Vice President of Compliance and Corporate Secretary.

Press Release

DISCLAIMER

Small Cap Exclusive is owned and operated by King Tide Media, LLC, which is a US based corporation & has been compensated $120,000 from Coeptis Therapeutics for profiling COEP. We own ZERO shares in COEP.

Full Disclaimer

Stay in the lopp :

ArQule, Inc. (NASDAQ:ARQL) Stock Hits 17-Year...

Biotech company ArQule, Inc. (NASDAQ:ARQL), which is involved in manufacturing precision cancer medicines, has been one of the most

Vivid Seats SEAT Stock Price, are you kidding...

Vivid Seats SEAT Stock Price is finally showing some life as it reverses trend. SEAT stock quote is up 15% in the last

Voce Capital is Buying Cutera Inc. (NASDAQ:CU...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cutera Inc. (NASDAQ:CUTR) reported that Voce Capital has picked up

related post

Skip to content